Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 19.

Huys, Quentin (2014). Computational Psychiatry. In: Jäger, D; Jung, R. Encyclopaedia of Computational Neuroscience. Berlin Heidelberg: Springer, online.

Schackert, G; Pinzer, T; Kortmann, R D; Weller, M (2011). Hirntumoren. In: Schlag, P M; Bamberg, M; Jäger, D. Interdisziplinäre Entscheidungswege in der Onkologie. Köln: Deutscher Ärzte-Verlag, 41-47.

Giger, O; Caduff, R; O'Meara, A; Diener, P A; Knuth, A; Jäger, D; Moch, H; Varga, Z (2010). Frequent expression of the breast differentiation antigen NY-BR-1 in mammary and extramammary Paget's disease. Pathology international, 60(11):726-734.

Maciejewska Rodrigues, H; Al-Shamisi, M; Hemmatazad, H; Ospelt, C; Bouton, M C; Jäger, D; Cope, A P; Charles, P; Plant, D; Distler, J H W; Gay, R E; Michel, B A; Knuth, A; Neidhart, M; Gay, S; Jüngel, A (2010). Functional autoantibodies against serpin E2 in rheumatoid arthritis. Arthritis and Rheumatism, 62(1):93-104.

Bauer, S; Oosterwijk-Wakka, J C; Adrian, N; Oosterwijk, E; Fischer, E; Wüest, T; Stenner, F; Perani, A; Cohen, L S; Knuth, A; Divgi, C; Jäger, D; Scott, A M; Ritter, G; Old, L J; Renner, C (2009). Targeted therapy of renal cell carcinoma: synergistic activity of cG250-TNF and IFNg. International Journal of Cancer, 125(1):115-123.

Atmaca, A; Al-Batran, S E; Neumann, A; Kolassa, Y; Jäger, D; Knuth, A; Jäger, E (2009). Whole-body hyperthermia (WBH) in combination with carboplatin in patients with recurrent ovarian cancer - A phase II study. Gynecologic oncology, 112(2):384-388.

Theurillat, J P; Zürrer-Härdi, U; Varga, Z; Barghorn, A; Saller, E; Frei, C; Storz, M; Behnke, S; Seifert, Burkhardt; Fehr, M; Fink, D; Rageth, C; Linsenmeier, C; Pestalozzi, B; Chen, Y T; Knuth, A; Jäger, D; Moch, H (2008). Distinct expression patterns of the immunogenic differentiation antigen NY-BR-1 in normal breast, testis and their malignant counterparts. International Journal of Cancer, 122(7):1585-1591.

Theurillat, J P; Zürrer-Härdi, U; Varga, Z; Storz, M; Probst-Hensch, N M; Seifert, Burkhardt; Fehr, M K; Fink, D; Ferrone, S; Pestalozzi, B; Jungbluth, A A; Chen, Y T; Jäger, D; Knuth, A; Moch, H (2007). NY-BR-1 protein expression in breast carcinoma: a mammary gland differentiation antigen as target for cancer immunotherapy. Cancer Immunology, Immunotherapy, 56(11):1723-1731.

Theurillat, J P; Ingold, F; Freitag, C; Zippelius, A; Varga, Z; Seifert, Burkhardt; Chen, Y T; Jäger, D; Knuth, A; Moch, H (2007). NY-ESO-1 protein expression in primary breast carcinoma and metastases - correlation with CD8+ T-cell and CD79a+ plasmacytic/B-cell infiltration. International Journal of Cancer, 120(11):2411-2417.

Trojan, A; Tinguely, M; Vallet, S; Seifert, Burkhardt; Jenni, B; Zippelius, A; Witzens-Harig, M; Mechtersheimer, G; Ho, A; Goldschmidt, H; Jäger, D; Boccadoro, M; Ladetto, M (2006). Clinical significance of cyclooxygenase-2 (COX-2) in multiple myeloma. Swiss Medical Weekly, 136(25-26):400-403.

von Minckwitz, G; Harder, S; Hövelmann, S; Jäger, E; Al-Batran, S E; Loibl, S G; Atmaca, A; Cimpoiasu, C; Neumann, A M; Abera, A; Knuth, A L; Kaufmann, M; Jäger, D; Maurer, A B; Wels, W S (2005). Phase I clinical study of the recombinant antibody toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas. Breast Cancer Research, 7(5):R617.

Jäger, E; Gnjatic, S; Nagata, Y; Stockert, E; Jäger, D; Karbach, J; Neumann, A; Rieckenberg, J; Chen, Y T; Ritter, G; Hoffman, E; Arand, M; Old, L J; Knuth, A (2000). Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers. Proceedings of the National Academy of Sciences of the United States of America, 97(22):12198-12203.

Jäger, E; Nagata, Y; Gnjatic, S; Wada, H; Stockert, E; Karbach, J; Dunbar, P R; Lee, S Y; Jungbluth, A; Jäger, D; Arand, M; Ritter, G; Cerundolo, V; Dupont, B; Chen, Y T; Old, L J; Knuth, A (2000). Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses. Proceedings of the National Academy of Sciences of the United States of America, 97(9):4760-4765.

Jäger, E; Jäger, D; Karbach, J; Chen, Y T; Ritter, G; Nagata, Y; Gnjatic, S; Stockert, E; Arand, M; Old, L J; Knuth, A (2000). Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma. Journal of Experimental Medicine, 191(4):625-630.

Jäger, E; Stockert, E; Zidianakis, Z; Chen, Y T; Karbach, J; Jäger, D; Arand, M; Ritter, G; Old, L J; Knuth, A (1999). Humoral immune responses of cancer patients against "Cancer-Testis" antigen NY-ESO-1: correlation with clinical events. International Journal of Cancer, 84(5):506-510.

Jäger, E; Chen, Y T; Drijfhout, J W; Karbach, J; Ringhoffer, M; Jäger, D; Arand, M; Wada, H; Noguchi, Y; Stockert, E; Old, L J; Knuth, A (1998). Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. Journal of Experimental Medicine, 187(2):265-270.

Jäger, E; Ringhoffer, M; Altmannsberger, M; Arand, M; Karbach, J; Jäger, D; Oesch, F; Knuth, A (1997). Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma. International Journal of Cancer, 71(2):142-147.

Jäger, E; Ringhoffer, M; Arand, M; Karbach, J; Jäger, D; Ilsemann, C; Hagedorn, M; Oesch, F; Knuth, A (1996). Cytolytic T cell reactivity against melanoma-associated differentiation antigens in peripheral blood of melanoma patients and healthy individuals. Melanoma research, 6(6):419-425.

Jäger, E; Ringhoffer, M; Dienes, H P; Arand, M; Karbach, J; Jäger, D; Ilsemann, C; Hagedorn, M; Oesch, F; Knuth, A (1996). Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo. International Journal of Cancer, 67(1):54-62.

This list was generated on Wed Oct 18 22:16:06 2017 CEST.